FDA Investigator Kayla V Sprague
Kayla V Sprague has conducted inspections on 27 sites in 2 countries as of 30 May 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
27
Last Inspection Date:
30 May 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America,
Puerto Rico
FDA Investigators that have inspected at least one site in common with Kayla V Sprague:
Aaron J Fox,
Adam R Cooke,
Andrew B Bevill,
Annette Melendez,
Barbara T Carmichael,
Bill Tacket, Jr,
Brooke K Higgins,
Camerson E Moore,
Caroline Strasinger,
Caryn M Mcnab,
CDR Ileana Barreto Pettit,
Cheryl A Clausen,
Christie A Soto,
Christos G Tsingelis,
Clinton J Lott,
Daryl A Dewoskin,
David P King,
Dr. Dominick Roselle,
Dr. Ralph M Bernstein, PhD,
Edward H Maticka,
Ethan P Stegman,
Frederic W French, III,
Gregory Price,
Ian F Deveau,
Janice M Hickok,
Jennifer A Robinson,
Jennifer L Bridgewater,
Jennifer Lalama,
Jennifer M Menendez,
Jessica L Pressley,
Jessica P Mcalister,
Joanne E King,
Jogy George,
Jolanna A Norton,
Jose Perez Soto,
Jose Velez,
Joshua J Silvestri,
June P Page,
Justine Tomasso,
Kari M Johansen,
Larry K Hampton,
Laura Fontan, MS,
LCDR Michael H Tollon,
Leo J Lagrotte,
Libia M Lugo,
Lillian Mcolon Mcknight,
Linda K Matheny,
Logan T Williams,
Lorie S Hannappel,
Lourdes Andujar,
LT Kimberly M Hull,
LT Richard A Lyght,
Luis Mburgos Medero,
Lynne Ensor,
Marian E Ramirez,
Megan T Ziegler,
Mizanne E Lewis,
Monica Cburgos Garcia,
Moraima Jramos Valle,
Nakesha J Jackson,
Naveen B Kanthamneni,
Nicole E Knowlton,
Noreen Muñiz,
Pamela N Agaba,
Paul L Figarole, Jr,
Philippa Hillyer,
Robert C Coleman,
Rosario D'costa,
Roy R Rinc,
Saleem A Akhtar,
Salvatore N Randazzo,
Samantha J Pinizzotto, D V M,
Sarah E Mcmullen,
Sarah Ibrahim,
Saundrea A Munroe,
Scott A Jepson,
Scott T Ballard,
Sha'tina R Alridge,
Stanley B Eugene, BS, BME,
Steven D Dittert,
Susan O Oladeji,
Suzanne N Vallez,
Torrance J Slayton,
Tracy L Reed,
Victor Spanioli,
Virginia L Meeks,
Vivin George,
Yifan Wang
Kayla V Sprague's Documents
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more